The document is a time table for the third year MBBS batch for the week of February 19th-23rd 2024. It outlines the daily schedule and topics to be covered for the Infectious Disease module on immunopathogenesis. The week will focus on classification of viruses, bacterial and viral pathogenesis, host defense against bacterial infections, anti-viral drugs, and epidemiology and control measures of influenza, yellow fever and chickenpox. Practical sessions include acid-fast staining in pathology and pharmaceutical preparations in pharmacology.
The document is a time table for the third year MBBS batch for the week of February 19th-23rd 2024. It outlines the daily schedule and topics to be covered for the Infectious Disease module on immunopathogenesis. The week will focus on classification of viruses, bacterial and viral pathogenesis, host defense against bacterial infections, anti-viral drugs, and epidemiology and control measures of influenza, yellow fever and chickenpox. Practical sessions include acid-fast staining in pathology and pharmaceutical preparations in pharmacology.
The document is a time table for the third year MBBS batch for the week of February 19th-23rd 2024. It outlines the daily schedule and topics to be covered for the Infectious Disease module on immunopathogenesis. The week will focus on classification of viruses, bacterial and viral pathogenesis, host defense against bacterial infections, anti-viral drugs, and epidemiology and control measures of influenza, yellow fever and chickenpox. Practical sessions include acid-fast staining in pathology and pharmaceutical preparations in pharmacology.
The document is a time table for the third year MBBS batch for the week of February 19th-23rd 2024. It outlines the daily schedule and topics to be covered for the Infectious Disease module on immunopathogenesis. The week will focus on classification of viruses, bacterial and viral pathogenesis, host defense against bacterial infections, anti-viral drugs, and epidemiology and control measures of influenza, yellow fever and chickenpox. Practical sessions include acid-fast staining in pathology and pharmaceutical preparations in pharmacology.
WEEK 2: INFECTIOUS DISEASE MODULE Theme 1: Immuno-pathogenesis MONDAY TUESDAY WEDNESDAY THURSDAY FRIDAY TIME 19-02-2024 20-02-2024 21-02-2024 22-02-2024 23-02-2024 08:15-09:30 08.00 ID-S2-Micb-7 HOSPITAL HOSPITAL HOSPITAL HOSPITAL TO Host defense against POSTING POSTING POSTING POSTING 10.15 bacterial infection Dr.Razia 09:30-10:30 10:15 ID-S2-Pharm-4 TO BREAK & TRAVELTIME Anti-viral drugs-2 10:45 Dr.Muzna Dar ID-S2-Micb-2 ID-S2-Micb-5 10-45 ID-S2-Micb-4 BREAK10:30 TO 11:00 Classification & ID-S2-Micb-6 TO Bacterial Bacterial structure of virus Viral pathogenesis 11:00 TO 12:00 11.30 Pathogenesis-I pathogenesis-II Dr.Abdul Karim Dr.Razia PAR-S-2-ETH-1 AM Dr.Abdul Karim Dr.Abdul Karim Informed Consent in 11.30 ID-S2-Path-5 ID-S2-Pharm-3 Clinical Settings and Consent Qisas & Diyat TO Chronic inflammation Anti-viral drugs -1 Research Dr.Akbar Kazi Ordinance-1 12.15 Prof: Dr. Farzana Dr.Muzna Dar Dr.Ali Bux Rajpar PM Memon Dr.Akbar Kazi 12:00-1:00 CBLWILL BE PAR-S-2-CM-8 PAR-S-2-CM-9 CONDUCTED BY PAR-S-2-CM-7 THE DEPARTMENT Epidemiology & Epidemiology & 12:15 Epidemiology & control measure of OF PATHOLOGY Mechanical Injuries-3 control measure of To Control Measure of yellow fever AND Dr.Shahla Imran Chickenpox 1:00 Influenza PHARMACOLOGY Dr.Mushtaq Prof:Dr.Najeeb Dr.Mushtaq Dr.Aqsa And Channar Memon Dr.Durgha Dr.Muhammad Ali Dr Naveen, Dr Sofia 1:00- Prayers And Break 1:30 Group C+D: Group A+B: Forensic Medicine Forensic (venue) Medicine(venue) Group A+B: 3rd-year Lecture Hall 1:00 To 3:00 PM Group C+D: 3rd-year Lecture Hall 1:3OTO Pathology Lab Group A+B JUMMA PRAYERS Pathology Lab Group C+D 03.00 Group C+D: Forensic Medicine & Group A+B: Forensic Medicine PM Pharmacology (venue) Self-Study Pharmacology (venue) 4th-year Lecture Hall 4th-year Lecture Hall
Pathology Lab: Acid-fast staining Dr.Aqsa And Dr.Durgha
Effect of 0.5% Povidone Iodine On The Nasopharyngeal and Oropharyngeal Viral Loads in Patients With COVID 19: A Double Blind Placebo Controlled Randomized Clinical Trial